{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:25:19Z","timestamp":1771269919418,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Antimicrobial resistance (AMR) is a global concern, and antibiotic use has risen throughout the COVID-19 pandemic. Up to 75% of COVID-19 patients are treated with antibiotics despite little evidence for their use. A retrospective study from 6 March 2020 (the start of the pandemic in Serbia) to 31 December 2021 was conducted at the Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia. In total, 523 patients with a microbiological diagnosis of COVID-19 were included. Patient data were analysed, including antibiotic use before and after admission. Pre-admission use of antibiotics for COVID-19 treatment was documented in more than half of patients (58.1%), of which a third (34.1%) used more than one antibiotic. Macrolides, cephalosporins, and fluoroquinolones were mainly used, most frequently among patients aged between 31\u201345 years (75.2%). Prior antibiotic use was associated with a longer duration of illness at admission (8.8 vs. 5.7, p &lt; 0.001), oxygen therapy upon admission (27.6% vs. 16.0%, p = 0.002), and a lower vaccination rate (60.7% vs. 50.7%, p = 0.04). When hospitalised, 72.1% of patients received antibiotics, primarily cephalosporins (71.9%). Significant efforts are needed to reduce antibiotic use in the community and improve prescribing rates by healthcare professionals.<\/jats:p>","DOI":"10.3390\/antibiotics11070847","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T10:39:13Z","timestamp":1656153553000},"page":"847","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Antibiotic (Mis)Use in COVID-19 Patients before and after Admission to a Tertiary Hospital in Serbia"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-911X","authenticated-orcid":false,"given":"Aleksa","family":"Despotovi\u0107","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-2277","authenticated-orcid":false,"given":"Aleksandra","family":"Bara\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Clinical Pharmacotherapy, Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-8645","authenticated-orcid":false,"given":"Teodora","family":"Cucani\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacotherapy, Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-4897","authenticated-orcid":false,"given":"Ksenija","family":"Cucani\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacotherapy, Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Stevanovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Clinical Pharmacotherapy, Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"ref_1","unstructured":"(2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiph.2021.02.001","article-title":"Antibiotics in treatment of COVID-19 complications: A review of frequency, indications, and efficacy","volume":"14","author":"Chedid","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ng, T.M., Ong, S.W.X., Loo, A.Y.X., Tan, S.H., Tay, H.L., Yap, M.Y., Lye, D.C., Lee, T.H., and Young, B.E. (2022). Antibiotic Therapy in the Treatment of COVID-19 Pneumonia: Who and When?. Antibiotics, 11.","DOI":"10.3390\/antibiotics11020184"},{"key":"ref_5","unstructured":"European Centre for Disease Prevention and Control (2021). Antimicrobial Consumption in the EU\/EEA (ESAC-Net)\u2013Annual Epidemiological Report 2020."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tomas, A., Pavlovi\u0107, N., Stilinovi\u0107, N., Horvat, O., Paut-Kusturica, M., Dugand\u017eija, T., Tomi\u0107, Z., and Sabo, A. (2021). Increase and Change in the Pattern of Antibiotic Use in Serbia (2010\u20132019). Antibiotics, 10.","DOI":"10.3390\/antibiotics10040397"},{"key":"ref_7","unstructured":"European Centre for Disease Prevention and Control & World Health Organization (2022). Regional Office for Europe. (Antimicrobial Resistance Surveillance in Europe 2022\u20132020 Data, World Health Organization. Regional Office for Europe."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11096-017-0461-3","article-title":"Self-medication with antibiotics in Serbian households: A case for action?","volume":"39","author":"Tomas","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1089\/mdr.2020.0619","article-title":"The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review","volume":"27","author":"Alhussain","year":"2021","journal-title":"Microb. Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4269\/ajtmh.21-0603","article-title":"Antibiotic Overuse for COVID-19: Are We Adding Insult to Injury?","volume":"105","author":"Abdela","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Llor, C., Ouchi, D., Giner-Soriano, M., Garc\u00eda-Sangen\u00eds, A., Bjerrum, L., and Morros, R. (2021). Correlation between Previous Antibiotic Exposure and COVID-19 Severity. A Population-Based Cohort Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111364"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e14081","DOI":"10.1111\/ijcp.14081","article-title":"Antibiotic misuse and compliance with infection control measures during COVID-19 pandemic in community pharmacies in Egypt","volume":"75","author":"Elsayed","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00038-020-01448-6","article-title":"Serbian students\u2019 knowledge, attitudes and behaviour towards antibiotic use: Is there room for improvement?","volume":"65","author":"Horvat","year":"2020","journal-title":"Int. J. Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.21101\/cejph.a4093","article-title":"Antibiotics in Serbian Households: A Source of Potential Health and Environmental Threats?","volume":"23","author":"Kusturica","year":"2015","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fpubh.2018.00091","article-title":"Are There Striking Differences in Outpatient Use of Antibiotics Between South Backa District, Serbia, and Some Scandinavian Countries?","volume":"6","author":"Horvat","year":"2018","journal-title":"Front. Public Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"106462","DOI":"10.1016\/j.ijantimicag.2021.106462","article-title":"Evaluation of early antibiotic use in patients with non-severe COVID-19 without bacterial infection","volume":"59","author":"Yin","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_17","first-page":"CD015025","article-title":"Antibiotics for the treatment of COVID-19","volume":"10","author":"Popp","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3325\/cmj.2022.63.53","article-title":"The effect of outpatient antibiotic treatment of coronavirus disease 2019 on the outcomes in the emergency department: A propensity score matching study","volume":"63","author":"Grabovac","year":"2022","journal-title":"Croat. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S0950268814001125","article-title":"Trends in macrolide resistance of respiratory tract pathogens in the paediatric population in Serbia from 2004 to 2009","volume":"143","author":"Mijac","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgar.2018.10.022","article-title":"Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997\u20132017","volume":"16","author":"Kastrin","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmi.2021.10.013","article-title":"The impact of COVID-19 on community antibiotic use in Canada: An ecological study","volume":"28","author":"Knight","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1017\/ice.2020.1291","article-title":"Changes in antimicrobial utilization during the coronavirus disease 2019 (COVID-19) pandemic after implementation of a multispecialty clinical guidance team","volume":"42","author":"Staub","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_23","unstructured":"Radna Grupa za Izradu Nacionalnog Vodica Dobre Klinicke Prakse Ministarstva Zdravlja Republike Srbije (2022, April 30). Nacionalni Vodic Dobre Klinicke Prakse. Racionalna Upotreba Antibiotika, Available online: https:\/\/www.zdravlje.gov.rs\/tekst\/335899\/novi-nacionalni-vodic-za-racionalnu-upotrebu-antibiotika-.php."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/7\/847\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:08Z","timestamp":1760139548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/7\/847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["antibiotics11070847"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11070847","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}